Dr Sue Wilson

Publications


Journals

  • Bonaventure P; Dugovic C; Kramer M; De Boer P; Singh J; Wilson S; Bertelsen K; Di J; et alShelton J; Aluisio L; Dvorak L; Fraser I; Lord B; Nepomuceno D; Ahnaou A; Drinkenburg W; Chai W; Dvorak C; Carruthers N; Sands S; Lovenberg T. (8 May 2012). Translational evaluation of JNJ-18038683, a 5-HT7 receptor antagonist, on REM sleep and in major depressive disorder. J Pharmacol Exp Ther. DOI.
  • Wilson S; Argyropoulos S. (Apr 2012). Sleep in schizophrenia: time for closer attention. Br J Psychiatry. 200:273-274. DOI.
  • Wilson S. (Jun 2009). Emerging therapies for sleep disorders. Br J Hosp Med (Lond). 70:327-331.
  • Williams KE; Mann TM; Chamberlain S; Smith A; Wilson S; Griffiths GD; Bowditch AP; Scott EA; et alPearce PC. (Jun 2006). Multiple vaccine and pyridostigmine interactions: effects on EEG and sleep in the common marmoset. Pharmacol Biochem Behav. 84:282-293. DOI.
  • Wilson S; Bailey J; Rich A; Adrover M; Nutt DJ. (1 Oct 2002). Using sleep to measure relative 5HT uptake blockade. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 12:S200-S200.
  • Watson BJ; Wilson S; Griffin L; Kalk NJ; Taylor LG; Munafo MR; Lingford-Hughes AR; Nutt DJ. (1 Jul 2011). A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol-dependent subjects. PSYCHOPHARMACOLOGY. 216:121-129. Author weblink DOI.
  • Glue P; Bailey J; Wilson S; Hudson A; Nutt DJ. (1992). Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements. Life Sci. 50:PL25-PL30.
  • Weinstein A; Wilson S; Bailey J; Myles J; Nutt D. (25 Oct 1997). Imagery of craving in opiate addicts undergoing detoxification. Drug Alcohol Depend. 48:25-31.
  • Green A; Hicks JA; Wilson. (2008). The experience of poor sleep and its consequences: a qualitative study involving people referred for cognitive-behavioural management of chronic insomnia. Journal of Occupational Therapy. 71:196-204.
  • Green A; Hicks JA; Wilson SJ. (2006). A qualitative study involving people seeking treatment for insomnia. British Sleep Society Annual Meeting, Cambridge 2006.
  • Green A; Hicks JA; Wilson SJ. (2006). Patient satisfaction with information about insomnia. British Sleep Society Annual Meeting, Cambridge 2006.
  • Wilson S; Argyropoulos S. (2005). Antidepressants and sleep: a qualitative review of the literature. Drugs. 65:927-947. Author weblink.
  • Green A; Hicks JA; Weekes R; Wilson SJ. (2005). A cognitive-behavioural group intervention for people with chronic insomnia: an initial evaluation. British Journal of Occupational Therapy. 68:518-522.
  • Weinstein AM; Malizia AL; Wilson SJ; Bailey JE; Nutt DJ. (1996). Imagery and PET imaging of craving experiences in abstinent opiate addicts. BAP summer meeting.
  • Glue PG; Wilson SJ; Ball DM; Nutt DJ. (1992). Benzodiazepine sensitivity in subjects with high and low trait neuroticism. Biological Psychiatry.
  • Wilson SJ; Glue PG; Nutt DJ. (1991). The effects of the �2-adrenoceptor antagonist idazoxan on sleep in normal volunteers. J.Psychopharm. 5,2:105-110.
  • Glue PG; Wilson SJ; Lawson C; Campling GM; Franklin M; Cowen PJ; Nutt DJ. (1991). Acute and chronic idazoxan in normal volunteers: biochemical, physiological and psychological effects. J.Psychopharm. 5,4:396-403.
  • Glue P; White E; Wilson S; Ball DM; Nutt DJ. (1991). Pharmacology of saccadic eye movements in man. 2. Effects of the alpha 2-adrenoceptor ligands idazoxan and clonidine. Psychopharmacology (Berl). 105:368-373.
  • Weinstein A; Wilson S; Bailey J; Nutt D. (1 Jan 1996). Sedative antidepressants impair visual detection mechanisms in humans. JOURNAL OF PSYCHOPHARMACOLOGY. 10:141-145. DOI.
  • Ball DM; Glue P; Wilson S; Nutt DJ. (1991). Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology (Berl). 105:361-367.
  • Friston KJ; Malizia AL; Wilson S; Cunningham VJ; Jones T; Nutt DJ. (1 Jan 1997). Analysis of dynamic radioligand displacement or ''activation'' studies. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 17:80-93. Author weblink.
  • GLUE P; WILSON S; COUPLAND N; BALL D; NUTT D. (1 Jan 1995). THE RELATIONSHIP BETWEEN BENZODIAZEPINE RECEPTOR SENSITIVITY AND NEUROTICISM. JOURNAL OF ANXIETY DISORDERS. 9:33-45. DOI.
  • WILSON S; GLUE P; NUTT D. (1 Jan 1992). FLUMAZENIL AND SACCADIC EYE-MOVEMENTS IN PATIENTS WITH PANIC DISORDER AND NORMAL CONTROLS. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 7:45-50. DOI.
  • Glue P; Wilson S; Campling GM; Knightly M; Franklin M; Cowen PJ; Nutt DJ. (May 1992). Alpha-2-adrenoceptor control of cortisol and ACTH in normal volunteers: preliminary open trial of the effects of acute and chronic idazoxan. Psychoneuroendocrinology. 17:261-266.
  • Paterson LM; Nutt DJ; Wilson SJ. (Sep 2011). Sleep and its disorders in translational medicine. J.Psychopharmacol. 25:1226-1234. Author weblink.
  • Lingford-Hughes AR; Wilson SJ; Cunningham VJ; Feeney A; Stevenson B; Brooks DJ; Nutt DJ. (Aug 2005). GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study. Psychopharmacology (Berl). 180:595-606. DOI.
  • Lingford-Hughes A; Wilson SJ; Feeney A; Grasby PG; Nutt DJ. (1 Aug 2005). A proof-of-concept study using [C-11]flumazenil PET to demonstrate that pagoclone is a partial agonist. PSYCHOPHARMACOLOGY. 180:789-791. DOI.
  • Lillywhite AR; Wilson SJ; Nutt DJ. (Apr 1994). Successful treatment of night terrors and somnambulism with paroxetine. Br J Psychiatry. 164:551-554.
  • Hicks JA; Argyropoulos SV; Rich AS; Nash JR; Bell CJ; Edwards C; Nutt DJ; Wilson SJ. (Jun 2002). Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression. Br J Psychiatry. 180:528-535.
  • Daglish MR; Williams TM; Wilson SJ; Taylor LG; Eap CB; Augsburger M; Giroud C; Brooks DJ; et alMyles JS; Grasby P; Lingford-Hughes AR; Nutt DJ. (Jul 2008). Brain dopamine response in human opioid addiction. Br J Psychiatry. 193:65-72. DOI.
  • Daglish MRC; Weinstein A; Malizia AL; Wilson S; Melichar JK; Britten S; Brewer C; Lingford-Hughes A; et alMyles JS; Grasby P; Nutt DJ. (1 Oct 2001). Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects. AMERICAN JOURNAL OF PSYCHIATRY. 158:1680-1686. Author weblink DOI.
  • Crofts HS; Wilson S; Muggleton NG; Nutt DJ; Scott EA; Pearce PC. (Dec 2001). Investigation of the sleep electrocorticogram of the common marmoset (Callithrix jacchus) using radiotelemetry. Clin Neurophysiol. 112:2265-2273.
  • Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S. (Sep 2009). Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone. J Sleep Res. 18:342-348. DOI.
  • Coupland NJ; Wilson SJ; Potokar JP; Bell C; Nutt DJ. (1 May 2003). Increased sympathetic response to standing in panic disorder. Psychiatry Res. 118:69-79.
  • Coupland NJ; Bailey JE; Wilson SJ; Horvath R; Nutt D. (Jun 1995). The effects of clonidine on cardiovascular responses to standing in healthy volunteers. Clin Auton Res. 5:171-177.
  • Coupland NJ; Wilson SJ; Potokar JP; Bell CE; Bailey JE; Nutt DJ. (Nov 1995). A comparison of the effects of phenelzine treatment with moclobemide treatment on cardiovascular reflexes. Int Clin Psychopharmacol. 10:229-238.
  • Coupland NJ; Bailey JE; Wilson SJ; Potter WZ; Nutt DJ. (Oct 1994). A pharmacodynamic study of the alpha 2-adrenergic receptor antagonist ethoxyidazoxan in healthy volunteers. Clin Pharmacol Ther. 56:420-429.
  • Carhart-Harris RL; Nutt DJ; Munafò M; Wilson SJ. (May 2009). Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol. 23:249-257. DOI.
  • Carhart-Harris RL; Nutt DJ; Munafo MR; Christmas DM; Wilson SJ. (Oct 2009). Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. Psychopharmacology (Berl). 206:187-196. DOI.
  • Wilson SJ; Nutt DJ; Alford C; Argyropoulos SV; Baldwin DS; Bateson AN; Britton TC; Crowe C; et alDijk D-J; Espie CA; Gringras P; Hajak G; Idzikowski C; Krystal AD; Nash JR; Selsick H; Sharpley AL; Wade AG. (1 Nov 2010). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. JOURNAL OF PSYCHOPHARMACOLOGY. 24:1577-1600. DOI.
  • Wilson SJ; Bailey JE; Nutt DJ. (Jun 2005). Dizziness produced by a potent 5HT(1A) receptor agonist (eptapirone) is not due to postural hypotension. Psychopharmacology (Berl). 179:895-896. DOI.
  • Wilson SJ; Bailey JE; Rich AS; Nash J; Adrover M; Tournoux A; Nutt DJ. (Nov 2005). The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. J Psychopharmacol. 19:609-613. DOI.
  • Wilson SJ; Rich AS; Rich NC; Potokar J; Nutt DJ. (Mar 2004). Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia. Int Clin Psychopharmacol. 19:77-84.
  • Bell C; Wilson S; Rich A; Bailey J; Nutt D. (Mar 2003). Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Psychopharmacology (Berl). 166:102-110. DOI.
  • Wilson SJ; Bailey JE; Rich AS; Adrover M; Potokar J; Nutt DJ. (Oct 2004). Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. Eur Neuropsychopharmacol. 14:367-372. DOI.
  • Wilson SJ; Bailey JE; Alford C; Weinstein A; Nutt DJ. (Dec 2002). Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood. J Psychopharmacol. 16:321-331.
  • Wilson SJ; Bell C; Coupland NJ; Nutt DJ. (May 2000). Sleep changes during long-term treatment of depression with fluvoxamine--a home-based study. Psychopharmacology (Berl). 149:360-365.
  • Wilson SJ; Bailey JE; Alford C; Nutt DJ. (2000). Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers. J Psychopharmacol. 14:378-386.
  • Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson SJ. (30 Sep 2003). Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Res. 120:179-190.
  • Wilson SJ; Lillywhite AR; Potokar JP; Bell CJ; Nutt DJ. (19 Jul 1997). Adult night terrors and paroxetine. Lancet. 350:185.
  • Wilson SJ; Glue P; Ball D; Nutt DJ. (Jan 1993). Saccadic eye movement parameters in normal subjects. Electroencephalogr Clin Neurophysiol. 86:69-74.
  • Wilson S; Nutt D. (Sep 2008). Drug treatment of chronic insomnia -- dawn at the end of a long night?. J Psychopharmacol. 22:703-706. DOI.
  • Wilson S; Nutt D. (Sep 2007). Management of insomnia: treatments and mechanismsi. Br J Psychiatry. 191:195-197. DOI.
  • Wilson S; Nutt D. (Mar 2005). Assessment and management of insomnia. Clin Med. 5:101-104.
  • Weinstein A; Feldtkeller B; Malizia A; Wilson S; Bailey J; Nutt DJ. (1998). Integrating the cognitive and physiological aspects of craving. J Psychopharmacol. 12:31-38.
  • Seddon K; Morris K; Bailey J; Potokar J; Rich A; Wilson S; Bettica P; Nutt DJ. (Jan 2011). Effects of 7.5% CO2 challenge in generalized anxiety disorder. J Psychopharmacol. 25:43-51. DOI.
  • Bell C; Vanderlinden H; Hiersemenzel R; Otoul C; Nutt D; Wilson S. (Sep 2002). The effects of levetiracetam on objective and subjective sleep parameters in healthy volunteers and patients with partial epilepsy. J Sleep Res. 11:255-263.
  • Potokar J; Coupland N; Wilson S; Rich A; Nutt D. (Sep 1999). Assessment of GABA(A)benzodiazepine receptor (GBzR) sensitivity in patients on benzodiazepines. Psychopharmacology (Berl). 146:180-184.
  • Potokar J; Lawson C; Wilson S; Nutt D. (15 Dec 1999). Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder. Biol Psychiatry. 46:1709-1711.
  • Potokar J; Coupland N; Glue P; Groves S; Malizia A; Bailey J; Wilson S; Nutt D. (Sep 1997). Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study. Alcohol Alcohol. 32:605-611.
  • Paterson LM; Nutt DJ; Ivarsson M; Hutson PH; Wilson SJ. (1 Jul 2009). Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers. JOURNAL OF PSYCHOPHARMACOLOGY. 23:487-494. Author weblink DOI.
  • Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M. (Jul 2009). Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption. J Psychopharmacol. 23:475-486. DOI.
  • Paterson LM; Wilson SJ; Nutt DJ; Hutson PH; Ivarsson M. (1 May 2007). A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers. PSYCHOPHARMACOLOGY. 191:943-950. Author weblink DOI.
  • Nutt DJ; Besson M; Wilson SJ; Dawson GR; Lingford-Hughes AR. (Dec 2007). Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology. 53:810-820. DOI.
  • Nutt DJ; Wilson S. (1999). Evaluation of severe insomnia in the general population--implications for the management of insomnia: the UK perspective. J Psychopharmacol. 13:S33-S34.
  • Nutt DJ; Wilson SJ; Coupland NJ. (Jan 1995). Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders. Int Clin Psychopharmacol. 9 Suppl 4:53-59.
  • Nutt D; Wilson S; Paterson L. (2008). Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 10:329-336.
  • Bell C; Wilson S; Nutt DJ. (1998). Pindolol augmentation of sertraline in resistant depression and its effect on sleep. J Psychopharmacol. 12:105-107.
  • Nash JR; Wilson SJ; Potokar JP; Nutt DJ. (28 Oct 2003). Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology. 61:1161.
  • Malizia AL; Gunn RN; Wilson SJ; Waters SH; Bloomfield PM; Cunningham VJ; Nutt DJ. (1 Jan 1996). Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: Direct measurement of drug occupancy and effects on the human brain in vivo. NEUROPHARMACOLOGY. 35:1483-1491. Author weblink DOI.
  • Lingford-Hughes AR; Daglish MRC; Stevenson BJ; Feeney A; Pandit SA; Wilson SJ; Myles J; Grasby PM; et alNutt DJ. (1 Mar 2006). Imaging alcohol cue exposure in alcohol dependence using a PET O-15-H2O paradigm: results from a pilot study. ADDICTION BIOLOGY. 11:107-115. Author weblink DOI.
  • Daglish MRC; Weinstein A; Malizia AL; Wilson S; Melichar JK; Lingford-Hughes A; Myles JS; Grasby P; et alNutt DJ. (1 Dec 2003). Functional connectivity analysis of the neural circuits of opiate craving: "more" rather than "different"?. NEUROIMAGE. 20:1964-1970. Author weblink DOI.

Books

  • Wilson S; Nutt DJ. Sleep disorders. Oxford University Press (2008).

Conferences

  • Wilson SJ; Paterson LM; Durant CF; Sinclair L; Rich AS; Wood B; Lightman S; Nutt DJ; et alMalizia AL. ACUTE EFFECTS OF HIGH DOSE HYDROCORTISONE ON SLEEP IN PATIENTS WITH TREATMENT RESISTANT DEPRESSION: A DOUBLE BLIND PLACEBO CONTROLLED STUDY. Summer Meeting of the British-Association-for-Psychopharmacology, 24 Jul 2011 - 27 Jul 2011. 25:A23-A23. SAGE PUBLICATIONS LTD (1 Aug 2011). Author weblink.
  • Wilson S; Phillips S; Lightman SL; Nutt DJ. Sleep stages and automatic overnight cortisol sampling. 21st Congress of the European-College-of-Neuropsychopharmacology, 30 Aug 2008 - 3 Sep 2008. 18:S584-S585. ELSEVIER SCIENCE BV (1 Aug 2008).
  • Phillips S; Lightman S; Nutt D; Wilson S. Sleep stages and automatic overnight cortisol sampling. 19th Congress of the European-Sleep-Research-Society, 9 Sep 2008 - 13 Sep 2008. 17:228-228. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2008).
  • Durant C; Wilson S; Paterson L; Nutt D; Gill S; Patel N; Malizia A. Sleep changes during deep brain stimulation for treatment resistant depression: preliminary findings from a case study. European-College-of-Neuropsychopharmacology Workshop on Neuropsychopharmacology for Young Scientists in Europe, 5 Mar 2009 - 8 Mar 2009. 19:S67-S68. ELSEVIER SCIENCE BV (1 Mar 2009). Author weblink.
  • Durant CF; Malizia AL; Paterson LM; Rich AS; Nutt DJ; Gill S; Patel NK; Wilson S. DEEP BRAIN STIMULATION IN THE SUBGENUAL CINGULATE ALTERS REM SLEEP IN PATIENTS WITH TREATMENT RESISTANT DEPRESSION. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A54-A54. SAGE PUBLICATIONS LTD (1 Aug 2010).
  • Durant C; Malizia AL; Paterson L; Rich A; Nutt DJ; Gill S; Patel NK; Wilson S. Acute deep brain stimulation in the subgenual cingulate alters REM sleep in patients with treatment resistant depression. 23rd Congress Meeting of European-College-of-Neuropsychopharmacology, 28 Aug 2010 - 1 Sep 2010. 20:S343-S343. ELSEVIER SCIENCE BV (1 Aug 2010). Author weblink.
  • Watson BJ; Bowsher B; Wilson S; Taylor LG; Kalk NJ; Griffin L; Lingford-Hughes AR; Munafo M; et alNutt DJ. A pilot study of the effectiveness of D-cycloserine during cue-exposure therapy in abstinent alcohol dependent subjects. 22nd Congress of the European-College-of-Neuropsychopharmacology, 12 Sep 2009 - 16 Sep 2009. 19:S640-S640. ELSEVIER SCIENCE BV (1 Sep 2009).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook